Recombinant FGF23 (Burosumab Biosimilar) antibody
The Human Monoclonal anti-FGF23 (Burosumab Biosimilar) antibody is suitable to detect FGF23 (Burosumab Biosimilar) in samples from Human. It has been validated for FACS, BLI, ELISA, Func and SPR.
Catalog No. ABIN7675838
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant FGF23 (Burosumab Biosimilar) antibody (ABIN7675838)
Target
FGF23 (Burosumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This FGF23 (Burosumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-FGF23 Reference Antibody (burosumab)
-
Characteristics
- Anti-FGF23 Reference Antibody (burosumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- FGF23 (Burosumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q9GZV9
Target
-
You are here:
